164 related articles for article (PubMed ID: 22449255)
1. DNp73 improves generation efficiency of human induced pluripotent stem cells.
Lin Y; Cheng Z; Yang Z; Zheng J; Lin T
BMC Cell Biol; 2012 Mar; 13():9. PubMed ID: 22449255
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced DNp73 stabilization regulates Vegf-A expression and tumor angiogenesis similar to TAp73.
Dulloo I; Hooi PB; Sabapathy K
Cell Cycle; 2015; 14(22):3533-9. PubMed ID: 26267146
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms, function and clinical applications of DNp73.
Di C; Yang L; Zhang H; Ma X; Zhang X; Sun C; Li H; Xu S; An L; Li X; Bai Z
Cell Cycle; 2013 Jun; 12(12):1861-7. PubMed ID: 23708520
[TBL] [Abstract][Full Text] [Related]
4. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; Pützer BM
Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
[TBL] [Abstract][Full Text] [Related]
5. TAp73beta and DNp73beta activate the expression of the pro-survival caspase-2S.
Toh WH; Logette E; Corcos L; Sabapathy K
Nucleic Acids Res; 2008 Aug; 36(13):4498-509. PubMed ID: 18611950
[TBL] [Abstract][Full Text] [Related]
6. [EFFECT OF ANTI-CANCER DRUG DOXORUBICINE ON CYTOMEGALOVIRUS INFECTED HUMAN FIBROBLASTS].
Fedorova NE; Emelianova SS; Vinogradskaya GR; Chichev EV; Murzakova AV; Kirichenko AA; Verbenko VN; Kushch AA
Tsitologiia; 2015; 57(4):260-8. PubMed ID: 26349243
[TBL] [Abstract][Full Text] [Related]
7. p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming.
Martin-Lopez M; Maeso-Alonso L; Fuertes-Alvarez S; Balboa D; Rodríguez-Cortez V; Weltner J; Diez-Prieto I; Davis A; Wu Y; Otonkoski T; Flores ER; Menéndez P; Marques MM; Marin MC
Cell Death Dis; 2017 Sep; 8(9):e3034. PubMed ID: 28880267
[TBL] [Abstract][Full Text] [Related]
8. Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.
Wang J; Xie H; Gao F; Zhao T; Yang H; Kang B
Tumour Biol; 2016 Mar; 37(3):4203-12. PubMed ID: 26490992
[TBL] [Abstract][Full Text] [Related]
9. p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.
Testoni B; Schinzari V; Guerrieri F; Gerbal-Chaloin S; Blandino G; Levrero M
Oncogene; 2011 Jun; 30(23):2670-8. PubMed ID: 21399658
[TBL] [Abstract][Full Text] [Related]
10. The antiapoptotic DeltaNp73 is degraded in a c-Jun-dependent manner upon genotoxic stress through the antizyme-mediated pathway.
Dulloo I; Gopalan G; Melino G; Sabapathy K
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):4902-7. PubMed ID: 20185758
[TBL] [Abstract][Full Text] [Related]
11. p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control.
Meier C; Hardtstock P; Joost S; Alla V; Pützer BM
Cancer Res; 2016 Jan; 76(2):197-205. PubMed ID: 26554827
[TBL] [Abstract][Full Text] [Related]
12. p73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling.
Fernandez-Alonso R; Martin-Lopez M; Gonzalez-Cano L; Garcia S; Castrillo F; Diez-Prieto I; Fernandez-Corona A; Lorenzo-Marcos ME; Li X; Claesson-Welsh L; Marques MM; Marin MC
Cell Death Differ; 2015 Aug; 22(8):1287-99. PubMed ID: 25571973
[TBL] [Abstract][Full Text] [Related]
13. [TAp73α is Upregulated in the Most Common Human Cancers].
Iscan E; Karakülah G; Ekin U; Ozturk M; Uzuner H; Suner A
Mol Biol (Mosk); 2022; 56(2):320. PubMed ID: 35403622
[TBL] [Abstract][Full Text] [Related]
14. Functions, divergence and clinical value of TAp73 isoforms in cancer.
Logotheti S; Pavlopoulou A; Galtsidis S; Vojtesek B; Zoumpourlis V
Cancer Metastasis Rev; 2013 Dec; 32(3-4):511-34. PubMed ID: 23592418
[TBL] [Abstract][Full Text] [Related]
15. DNp73 a matter of cancer: mechanisms and clinical implications.
Buhlmann S; Pützer BM
Biochim Biophys Acta; 2008 Apr; 1785(2):207-16. PubMed ID: 18302944
[TBL] [Abstract][Full Text] [Related]
16. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
[TBL] [Abstract][Full Text] [Related]
17. The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis.
Holcakova J; Ceskova P; Hrstka R; Muller P; Dubska L; Coates PJ; Palecek E; Vojtesek B
Cell Mol Biol Lett; 2008; 13(3):404-20. PubMed ID: 18350258
[TBL] [Abstract][Full Text] [Related]
18. E1A activates transcription of p73 and Noxa to induce apoptosis.
Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M
J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378
[TBL] [Abstract][Full Text] [Related]
19. Suppression of acetylpolyamine oxidase by selected AP-1 members regulates DNp73 abundance: mechanistic insights for overcoming DNp73-mediated resistance to chemotherapeutic drugs.
Bunjobpol W; Dulloo I; Igarashi K; Concin N; Matsuo K; Sabapathy K
Cell Death Differ; 2014 Aug; 21(8):1240-9. PubMed ID: 24722210
[TBL] [Abstract][Full Text] [Related]
20. A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.
Engelmann D; Meier C; Alla V; Pützer BM
Oncogene; 2015 Aug; 34(33):4287-99. PubMed ID: 25381823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
